Toggle Sidebar
Home
AI Agent
Annotations
Watchlists
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
BNTX US
BioNTech SE American Depositary Receipt
(BNTX US)
$88.12
-1.55
1.73%
Ext:
$88.26
+0.15
0.17%
(Market Closed · 23:47:19 UTC)
Follow
SEC Filings by Owner
Select Filings
Ask in Filing
Insider Ownership
Sahin Ugur
(16)
Expand
4
Statement of changes in beneficial ownership
9 Oct
4
Statement of changes in beneficial ownership
7 Oct
4
Statement of changes in beneficial ownership
6 Oct
4
Statement of changes in beneficial ownership
2 Oct
4
Statement of changes in beneficial ownership
30 Sep
4
Statement of changes in beneficial ownership
28 Sep
4
Statement of changes in beneficial ownership
24 Sep
4
Statement of changes in beneficial ownership
22 Sep
4
Statement of changes in beneficial ownership
18 Sep
4
Statement of changes in beneficial ownership
16 Sep
Poetting Sierk
(3)
Expand
4
Statement of changes in beneficial ownership
13 May
4
Statement of changes in beneficial ownership
23 Apr
3
Initial statement of beneficial ownership
18 Mar
Hanekamp Annemarie
(2)
Expand
4
Statement of changes in beneficial ownership
13 May
3
Initial statement of beneficial ownership
18 Mar
Ryan James Timothy Patrick
(2)
Expand
4
Statement of changes in beneficial ownership
13 May
3
Initial statement of beneficial ownership
25 Mar
Jimenez Kylie
(2)
Expand
4
Statement of changes in beneficial ownership
13 May
3
Initial statement of beneficial ownership
25 Mar
Zapata Gomez Ramon
(2)
Expand
4
Statement of changes in beneficial ownership
13 May
3
Initial statement of beneficial ownership
25 Mar
Schaffert Susanne
(1)
Expand
3
Initial statement of beneficial ownership
26 Jun
Jeggle Helmut Wolfgang
(1)
Expand
3
Initial statement of beneficial ownership
18 Mar
Tureci Ozlem
(1)
Expand
3
Initial statement of beneficial ownership
18 Mar
Motschmann Michael
(1)
Expand
3
Initial statement of beneficial ownership
18 Mar
Wandschneider Ulrich
(1)
Expand
3
Initial statement of beneficial ownership
18 Mar
Blackwood Nicola Claire
(1)
Expand
3
Initial statement of beneficial ownership
25 Mar
Morawietz Anja
(1)
Expand
3
Initial statement of beneficial ownership
25 Mar
Staudigl Rudolf
(1)
Expand
3
Initial statement of beneficial ownership
25 Mar
Low-Friedrich Iris Katharina
(1)
Expand
3
Initial statement of beneficial ownership
26 Jun
≥5% Ownership
ATHOS KG
(7)
Expand
SC 13G/A
BioNTech SE
14 May
SC 13G/A
BioNTech SE
13 Nov 2024
SC 13G/A
BioNTech SE
7 Feb 2024
SC 13G/A
BioNTech SE
14 Feb 2023
SC 13G/A
BioNTech SE
11 Feb 2022
SC 13G/A
BioNTech SE
16 Feb 2021
SC 13G
BioNTech SE
12 Feb 2020
Medine GmbH
(6)
Expand
SC 13G/A
BioNTech SE
13 May 2025
SC 13G/A
BioNTech SE
14 Feb 2024
SC 13G/A
BioNTech SE
22 Feb 2023
SC 13G/A
BioNTech SE
14 Feb 2022
SC 13G/A
BioNTech SE
16 Feb 2021
SC 13G
BioNTech SE
13 Feb 2020
BioNTech SE
(2)
Expand
SC 13D
Autolus Therapeutics plc
21 Feb 2024
SC 13D
Neon Therapeutics, Inc.
23 Jan 2020
MIG Verwaltungs AG
(2)
Expand
SC 13G/A
BioNTech SE
16 Feb 2021
SC 13G
BioNTech SE
14 Feb 2020
Sahin Ugur
(1)
Expand
SC 13G/A
BioNTech SE
15 May
Financials & Metrics
Financials
Charting
Short Interest
Employees
